INTRODUCTION
Cancer of the breast is the most prevalent cancer in women worldwide and also in Iranian women. [1] [2] In spite of many progresses in identifying genetic markers and risk factors for breast cancer, approximately 70-80% of cases will occur in women without any known major predictor. [3] When there is no effectual primary prevention measures, screening, and early detection could be an important way for reducing the mortality rate of breast cancer and to prolong patients' life; it emphasizes on detecting cancer at an early stage when tumor size is preferably smaller than 1 cm, lymph nodes are negative and there is no evidence of distant spread. [4] . As a primary method for screening, mammography has been established and shown to reduce mortality from breast cancer about 30-50%. [5, 6] But still, in screening with mammography the sensitivity to nonpalpable cancer in women with ultrasound (US) has the potential to identify early, nodenegative cancers that not seen on mammography. [7] It has been greatly reported that in diagnosis of breast cancer US is more sensitive than mammography and had been shown to identify mammographically occult breast cancers in dense breasts. [5, [15] [16] [17] It is easily available and is largely inexpensive.
Ultrasound images the tissue to the chest wall; it is a crosssectional technique, which displays the tissue without overlap. [18, 19] However, the skill and time that is necessary to detect nonpalpable, small tumors with hand-held imaging has reduced widespread use of US and shortage of qualified personnel and lack of the uniformity limit wide implementation of this method. Low specificity of US can lead to higher rates of false positive results. [9] Previous studies showed different results; most of them concluded the possibility that ultrasonography may identify occult breast carcinoma in dense breasts. [20] [21] [22] But some showed a low cancer detection rate of ultrasonography in dense breasts and stated that adding ultrasonography to negative mammography seems to have limited costeffectiveness and is controversial for women who have no major risk factors other than dense breasts. [23, 24] However, women who have a personal history of breast cancer are at increased risk of contralateral interval cancer, so a tailored screening method should be used in this group of patients. [25] In this study, we aimed to assess the role of breast ultrasonography as a complement to unilateral mammography in screening of radiologically dense breasts in patients with unilateral previous mastectomy and no obvious new density in comparison to previous mammograms.
MATERIALS AND METHODS

Study design and participants
This was a cross-sectional study, which was carried out on 2012-2013. The study followed the Declaration of Helsinki on Biomedical Research Involving Human Subjects and was approved by the Ethics Committee from the Isfahan University of Medical Sciences. All participants provided written or oral informed consent.
The American College of Radiology (ACR) has developed a Breast Imaging Reporting And Data System (BI-RADS) classification for breast US examinations in 2003, [26] which is analogous to the BI-RADS classification for mammography, categorizing from ACR 1 to 5.
[27] The supplemental US for the detection of cancer are primarily appropriate for women with ACR breast density 3 or 4, because >90% of the women in whom cancer was detected by US had ACR breast density 3 or 4. [23, 28] Also based on ACR BI-RADS category for probability of malignancy in mammographic and ultrasonographic findings, BI-RADS categories 1-2 indicate negative or benign findings respectively, and BI-RADS categories 3-5 indicate probably benign, suspicious abnormality, and highly suggestive of malignancy. Category 0 is set for results that require additional imaging due to limited assessment. [27] Subjects were chosen from patients who came to seyed al shohada Hospital (Isfahan, Iran) for routine mammographic yearly screening, after mastectomy. All subjects met the following inclusion criteria: 1. 18-65 years aged women; 2. Asymptomatic subjects with previous history of unilateral mastectomy due to a known breast cancer; 3. Having at least one previous contralateral mammography through past years with ACR breast density 2-4 (scattered fibroglandular densities, heterogeneously dense or extremely radiographically dense breasts); 4. Presence of no new density in new mammography in comparison with previous mammography for subjects with ACR breast density 3-4; 5. Diagnosed with BI-RADS category 1-2 for malignancy for subjects with ACR density 2 in both consecutive mammograms.
A total of 267 individuals screened and 153 subjects met all inclusion and no exclusion criteria who assigned to study [Flow Chart 1]. There were 28 subjects with ACR breast density 2 and 125 with ACR breast density 3-4. We assumed subjects with ACR breast density 3-4 as BI-RADS category 0 for malignancy. Two subjects dropped out in the study process because of not participating in US imaging. Demographic data included age, duration of mastectomy and family history.
Procedures and variables assessment
Mammograms were carried out with a Planmeca device in standard cranio-caudal and medio-lateral oblique views, and breast US examinations were performed on a general electric S6 with a multi frequency linear probe (10-14 MHz). The breasts were scanned in radial and anti-radial planes. US examination was performed by an expert radiologist.
Physicians who did the US were blinded for results of mammography. 
Statistical methods
RESULTS
From 153 subjects, there were 28 (18.3%) subjects with ACR breast density 2 and 125 (81.7) with ACR breast density 3-4. In 28 subjects with ACR breast density 2, there were 16 (7.8%) subjects with BI-RADS 1, and 12 (10.5%) subjects with BI-RADS 2.
Mean (SD) age of 153 participants was 44.5 (9.6) years (range, 29-61 years). They were all asymptomatic with no known clinical findings. The mean (SD) years from mastectomy was 3.6 (1.1) years (range, 2-6 years).
In these participants, 16 (10.5%) subjects had family history of first degree relatives with breast cancer while 13 (8.5%) had family history of second-degree relatives with breast cancer. Three (1.1%) subjects had both family history of first-and second-degree relatives with breast cancer.
The subjects with ACR breast density 3-4 and ACR breast density 2, didn't differ in age, years of mastectomy and family history of breast cancer, significantly [ Table 1 ].
After screening with US, all of subjects with BI-RADS 0 in mammography who didn't have any new density, diagnosed with BI-RADS 1-2 ultrasonographically; there were 89 (71.8%) subjects with BI-RADS 1 and 35 (28.2%) subjects with BI-RADS 2.
Also all of the subjects with BI-RADS 1-2 in mammography, diagnosed with the BI-RADS 1 or 2 ultrasonographically; there were 15 (55.5%) subjects with BI-RADS 1 and 12 (44.4%) subjects with BI-RADS 2. Four patients with BI-RADS 2 in mammography diagnosed with BI-RADS 1 in US assessment; they had arterial calcification that is not detectable with US.
There was no one with BI-RADS 3-5 in all of the 151 subjects who screened by US [ Table 2 ].
Flow Chart 1: Study design flow chart 
DISCUSSION
The use of supplemental US for the detection of breast cancer is recommended as a supplemental screening for women who have dense breasts. [7] In this study, we assessed the usefulness of this method as a complement to mammography in screening of radiologically dense breasts other than essentially fatty (ACR breast density 2-4) for malignancy.
The results showed that in subjects with ACR breast density 3-4, when there was no new density in two consecutive mammograms, US also showed no possibility for malignancy (BI-RADS 1-2). And also in subjects with ACR breast density 2, when the mammographic results were BI-RADS 1-2, the US results was the same. This is in against with some recent studies. Leong et al. revealed the relevant of supplementary US screening in identifying early stage clinically and mammographically occult breast cancers in dense breast women. [29] Also, Shen et al. and Parris et al. showed that US is more sensitive than mammography for early detecting of breast cancer. They concluded that formal screening breast US as an adjunct to mammography increases cancer detection rate. [30, 31] On the other hand, this is consistent with Brancato et al. study that showed a low cancer detection rate, considerably lower compared to other clinical studies of US in dense breasts. [23] They stated that adding US to negative mammography in dense breasts seems to have limited costeffectiveness, and should not be used in routine practice. Also, sickles concluded that the use of screening US remains controversial between women who have no major risk factors other than dense breasts. [24] One of possible adverse effects of additional breast US is more rates of biopsy in the evaluated subjects (2.3-4.7%), which is substantially higher than the biopsy rates of about 1-2% resulting from mammographic screenings. [32] In addition, as the major limitation of US, is its low specificity, after biopsy the positive predictive value of US (mean 10.3%) was significantly lower than that of mammography (mean 38%), [33, 34] that is, 3 times more subjects need to undergo a biopsy per cancer detected. Although findings identified by US can be biopsied easily in a minimallyinvasive procedure, the psychological stress that women experience for biopsy because of a false-positive US result should be considered.
There is a need for prospective studies of second-line, riskadjusted, supplemental breast US screening in women with dense breast, performed within the frame work of population-based mammography screening-programs.
